The Latest Breaking News from Benchmark

Benchmark has decided to maintain its Buy rating of Cross Country Healthcare (NASDAQ:CCRN) and lower its price target from $42.00 to $37.00. Shares of Cross Country Healthcare are trading down 6.22% over the last 24 hours, at $17.33 per share.

Benchmark has decided to maintain its Buy rating of Zoom Video Comms (NASDAQ:ZM) and raise its price target from $124.00 to $128.00. Shares of Zoom Video Comms are trading up 5.68% over the last 24 hours, at $94.40 per share.

This article was originally published on Grand Cardone TV and appears here with permission. Is influencer marketing effective? More and more companies are starting to think so.

Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) Google decided to allow Spotify Technology SA (NYSE:SPOT) and other app developers to offer users an alternative third-party payment option alongside Google Play's option. KeyBanc analyst Justin Patterson saw the move as a win for digital content providers.  He viewed alternative payment options as a happy compromise that calmed regulators and…

Companies today are talking a great deal about decarbonisation and, for many, it has increasingly become a top priority

Expeditors International of Washington Inc (NASDAQ:EXPD) was initiated with a Hold rating by Benchmark analyst Christopher Kuhn. The analyst calls the company a "high-quality freight forwarder" that has taken benefit of the strong growth in the freight forwarding market. Kuhn expects Expeditors' revenue and operating margins to revert to normal levels as tight capacity in…

Lightning Emotors Inc (NYSE:ZEV) price target has been lowered to $9 (an upside of 91.7%) from $14 by Benchmark. Analyst Michael Ward reduced the price target to echo new revenue assumptions as chip shortages have extended into 2022. Meanwhile, the analyst maintained the Buy rating on the shares as he thinks postponed deliveries will…

Direct Digital Holdings Inc (NASDAQ: DRCT) is trading higher Wednesday after Benchmark analyst Daniel Kurnos initiated coverage on the stock with a Buy rating and announced a $8 price target.

Morgan Stanley analyst Brian Nowak lowered the price target on Facebook parent Meta Platforms Inc (NASDAQ:FB) to $325 from $360 and reiterated Overweight. The price target implies an upside of 59.7%. Nowak noted lower near-term monetization of Reels. Benchmark analyst Mark Zgutowicz harbored similar feelings and therefore initiated coverage on the stock with a Hold and without any…